Phospho-CTTN (Tyr466) Antibody

Shipped with Ice Packs
In Stock

Product Specs

Form
Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Lead Time
Typically, we can ship your orders within 1-3 business days of receipt. Delivery times may vary depending on the purchase method and location. For specific delivery times, please consult your local distributors.
Synonyms
Amplaxin antibody; CTTN antibody; EMS 1 antibody; EMS1 antibody; FLJ34459 antibody; Mammary tumor and squamous cell carcinoma associated antibody; Oncogene EMS1 antibody; p80/85 src substrate antibody; Src substrate cortactin antibody; SRC8_HUMAN antibody
Target Names
CTTN
Uniprot No.

Target Background

Function
Cortactin plays a crucial role in regulating the organization of the actin cytoskeleton and cell shape. It contributes to the formation of lamellipodia and facilitates cell migration. Moreover, cortactin is involved in the regulation of neuron morphology, axon growth, and the formation of neuronal growth cones. Through its interaction with CTTNBP2, it influences the regulation of neuronal spine density. In the context of cancer cells, cortactin plays a significant role in invasiveness and the formation of metastases. It also participates in focal adhesion assembly and turnover. In conjunction with ABL1 and MYLK, cortactin regulates cortical actin-based cytoskeletal rearrangement, which is crucial for sphingosine 1-phosphate (S1P)-mediated endothelial cell (EC) barrier enhancement. Furthermore, cortactin is involved in intracellular protein transport and endocytosis, modulating the levels of potassium channels present at the cell membrane. It also plays a role in receptor-mediated endocytosis via clathrin-coated pits. Cortactin is essential for the stabilization of KCNH1 channels at the cell membrane.
Gene References Into Functions
  1. Cortactin (CTTN) silencing in megakaryocyte (MK) phenocopies histone deacetylase 6 (HDAC6) inactivation and knockdown, leading to a significant proplatelet formation (PPF) defect. PMID: 29176689
  2. Cortactin expression in carcinoma cells, along with its established involvement in the EGFR pathway, suggests its potential as a therapeutic target for laryngeal squamous cell carcinoma. PMID: 28885660
  3. Cortactin depletion in HMEC-1 cells results in increased stress fiber contractility and endothelial barrier destabilization. The secretion of adrenomedullin, a barrier-stabilizing hormone that activates Rap1 and counteracts actomyosin contractility, was reduced in supernatants of cortactin-depleted endothelium. These findings indicate that cortactin regulates actomyosin contractility, ultimately influencing endothelial barrier integrity. PMID: 27357373
  4. Research indicates that cortactin-mediated p21Cip1 nuclear export and degradation facilitates MCP1-induced human aortic smooth muscle cell (HASMC) proliferation. PMID: 27363897
  5. Mena(INV) promotes invadopodium maturation by inhibiting the normal dephosphorylation of cortactin at tyrosine 421 by the phosphatase PTP1B. PMID: 27824079
  6. CTTN expression increases EGFR protein levels and enhances the activation of the MAPK signaling pathway. Furthermore, CTTN expression inhibits the ubiquitin-mediated degradation of EGFR by suppressing the coupling of c-Cbl with EGFR. PMID: 27903975
  7. A study revealed that PTBP1 facilitates colorectal cancer migration and invasion activities through the inclusion of cortactin exon 11. PMID: 28404950
  8. Research suggests that p27 directly promotes cell invasion by facilitating invadopodia turnover via the Rac1/PAK1/Cortactin pathway. PMID: 28287395
  9. Tyrosine dephosphorylation of the cytoskeletal scaffold, cortactin, recruits the RhoA antagonist SRGAP1 to relax adherens junctions in response to HGF. PMID: 28983097
  10. Cortactin binds to E-cadherin, and RhoA-induced phosphorylation by protein kinase D1 (PKD1; also known as PRKD1) at S298 impairs adherens junction assembly and supports their dissolution. PMID: 27179075
  11. PBF plays a unique role in regulating CTTN function, promoting endocrine cell invasion and migration. PMID: 27603901
  12. AMPK phosphorylation of cortactin followed by SIRT1 deacetylation modulates the interaction between cortactin and cortical-actin in response to shear stress. This AMPK/SIRT1 coregulated cortactin-F-actin dynamics is required for endothelial nitric oxide synthase subcellular translocation/activation and exhibits atheroprotective effects. PMID: 27758765
  13. Evidence suggests that cortactin promotes exosome secretion by stabilizing cortical actin-rich multivesicular late endosome docking sites. PMID: 27402952
  14. Cortactin may play a significant role in the development of oral tumors in humans. PMID: 27148699
  15. A dynamic TIP150-cortactin interaction orchestrates directional cell migration by coupling dynamic microtubule plus ends to the cortical cytoskeleton. PMID: 27451391
  16. Amplification of 11q13, resulting in overexpression of CTTN/CCND1, was the most prominent finding, observed in 13 out of 19 ESCC cases. PMID: 27877079
  17. The cortactin Tyr421 residue is required to promote cell proliferation both in vitro and in vivo. PMID: 27805253
  18. The expression of CTTN, Exo70, and MMP-9 in HCC cells was detected, and their relationship with the ability of migration and invasion of hepatoma carcinoma cells was evaluated. PMID: 27025610
  19. miR-542-3p inhibits the invasion of colorectal cancer cells by targeting CTTN. PMID: 26952924
  20. Cortactin expression in epithelial ovarian carcinoma was closely related to malignant biological behavior. PMID: 26243395
  21. MCP1-induced cortactin phosphorylation is dependent on PLCb3-mediated PKC activation, and siRNA-mediated down-regulation of either of these molecules prevents cortactin interaction with WAVE2. PMID: 26490115
  22. Findings reveal that Keap1 regulates cell migration by affecting the subcellular localization and activity of cortactin independently of its role in oxidant stress responses. PMID: 26602019
  23. Host cortactin, PKD1, and actin are recruited by Trypanosoma cruzi extracellular amastigotes, as demonstrated by experiments in fixed and live cells using time-lapse confocal microscopy. PMID: 26096820
  24. A study highlights the potential role of CCM3 in regulating tight junction complex organization and brain endothelial barrier permeability through CCM3-ERK1/2-cortactin cross-talk. PMID: 26385474
  25. Researchers identified and confirmed that Fra-1 affected the expression level of CTTN and EZR in vitro through LC-MS/MS analyses and western blot technology. PMID: 26330014
  26. Acetylation-mimicking mutants of alpha-tubulin and cortactin counteract HDAC6-induced ciliary disassembly. PMID: 26246421
  27. Cortactin is crucial for the invasion and migration of glioma cells, potentially promoting their migration and invasion by regulating lamellipodia formation, a process requiring the combination of cortactin and the Arp2/3 complex. PMID: 26238396
  28. Findings demonstrate that CTTN is significantly upregulated in colon cancer, and its ectopic expression promotes cell proliferation and tumorigenicity through EGFR-ERK pathway regulation, suggesting that CTTN plays a critical role in colon cancer progression. PMID: 26151562
  29. Results indicate that cortactin is involved in the regulation of apoptosis induced by VacA in gastric cells. PMID: 26289258
  30. The study investigated the expression of cortactin in HCT116 cells treated with one of the major components of Chansu, Cinobufagin. PMID: 26134506
  31. These findings suggest that this common cortactin variant may functionally contribute to ALI predisposition by impeding endothelial wound healing. PMID: 26361873
  32. Data suggests a model in which phosphatidylinositol 3,5-bisphosphate binding removes cortactin from late endosomal branched actin networks, promoting net actin turnover. PMID: 26323691
  33. Dysregulation of cortactin and HDAC6 is implicated in the invasiveness and migration of prostate cancer cells. PMID: 26112958
  34. These results imply that MTSS1 suppresses cell migration and invasion by inhibiting the expression of CTTN and serves as a prognostic biomarker in Glioblastomas. PMID: 25385572
  35. Upregulation of CTTN is critical for Vascular endothelial growth factor-C-mediated tumor growth and metastasis of esophageal squamous cell carcinoma. PMID: 25212831
  36. The cortactin SH3 domain contributes to podosome assembly, while fascin actin bundling is a master regulator of podosome disassembly in THP-1 macrophages and dendritic cells. PMID: 25601713
  37. Integrated omic analysis of oropharyngeal carcinomas reveals human papillomavirus-dependent regulation of the AP-1 pathway and elevated cortactin protein levels. PMID: 25271301
  38. This review focuses on recently published evidence that endothelial ABPs, such as cortactin, myosin, or alpha-actinin, regulate leukocyte extravasation by controlling actin dynamics, biomechanical properties of endothelia, and signaling pathways. PMID: 25848070
  39. c-src-mediated phosphorylation requires RTPAalpha. PMID: 24652832
  40. Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemia. PMID: 24532043
  41. Cortactin expression promoted the migration, invasion, and proliferation of SGC-7901 cells both in vivo and in vitro. PMID: 24696610
  42. Mechanistic investigations showed that VEGF-C increased CTTN expression by downregulating Dicer-mediated maturation of miR326, thereby relieving the suppressive effect of miR326 on CTTN expression. PMID: 25205106
  43. The association of cortactin with Pfn-1 is regulated by c-Abl-mediated cortactin phosphorylation. PMID: 24700464
  44. Data suggests that curcumin is an activator of non-receptor type 1 protein tyrosine phosphatase (PTPN1) and can reduce cell motility in colon cancer via dephosphorylation of pTyr(421)-cortactin (CTTN). PMID: 24465712
  45. Overexpression of cortactin (CTTN) was observed in 126/198 (63.6%) of esophageal squamous cell carcinoma cases and was significantly associated with lymph node metastasis (P = 0.000), pathologic stage (P = 0.000), and poor survival (P<0.001). PMID: 24551190
  46. Studies show that bladder cancer cells with cortactin knockdown have a reduced capacity to extravasate into the lung from the circulation, due to the decreased invasive character of invadopodia. PMID: 24549769
  47. Studies show that IQGAP1 functions as a hub linking HGF-induced signaling to microtubules and actin remodeling via EB1-IQGAP1-cortactin interactions. PMID: 25022754
  48. Expression of a charge-neutralizing cortactin mutant inhibited contraction and actin dynamics during contractile activation. PMID: 24920679
  49. Two amino acid residues confer different binding affinities of Abelson family kinase SRC homology 2 domains for phosphorylated cortactin. PMID: 24891505

Show More

Hide All

Database Links

HGNC: 3338

OMIM: 164765

KEGG: hsa:2017

UniGene: Hs.596164

Subcellular Location
Cytoplasm, cytoskeleton. Cell projection, lamellipodium. Cell projection, ruffle. Cell projection, dendrite. Cell projection. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cell projection, podosome. Cell junction. Cell junction, focal adhesion. Membrane, clathrin-coated pit. Cell projection, dendritic spine. Cytoplasm, cell cortex.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.